In a globalized world, Point-of-Care-Testing (POCT) needs to be more agile than the disease itself.
MONDIALAB PRO provides the end-to-end solution to this challenge as an innovative 360° Point-of-Care (POC) platform which enables one to receive, store and evaluate vast amounts of health data, generated by powerful, accurate and automated diagnostic tools.
With extensive experience in the field of immunoassays, Lab-on-a-Chip technologies and innovative product design, we are unceasingly developing progressive healthcare solutions.
We pride ourselves in exclusive collaboration with the University of Marseille, the world’s leading institute for research in the area of infectious and tropical diseases.
We and our associates are committed to shaping the future of healthcare together.
AES Venture Limited (AESV Group) presides over the biotech design, research & development company responsible for the development and implementation of the MONDIALAB PRO platform and delivering the platform to markets across the globe.
At the AESV Group, we aim to make simple and cost-efficient solutions available to everybody and help to save lives.